Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cystic renal cell carcinoma includes any malignant neoplasm of renal tubular epithelium which presents as a fluid-filled mass. Approximately 15 per cent of cases of renal cell carcinoma will be cystic on radiologic and pathologic examination. The clinical features of cystic renal cell carcinoma are similar to those which are solid. The radiographic and pathologic findings of cystic renal cell carcinoma are often more confusing and less specific than the findings of renal cell carcinoma which are predominantly solid. There are four basic pathologic mechanisms resulting in cystic renal cell carcinoma: intrinsic multiloculated growth; intrinsic unilocular growth (cystadenocarcinoma); cystic necrosis; and origin from the epithelial lining of a preexisting simple cyst. There are three basic radiologic patterns of cystic renal cell carcinoma: unilocular cystic mass, multiloculated cystic mass, and discrete mural nodule in a cystic mass. Cystic renal cell carcinoma is often extremely difficult to differentiate from non-neoplastic, benign neoplastic, and other malignant neoplastic masses utilizing radiologic studies alone. This review presents the clinical, pathologic, and radiographic features of cystic renal cell carcinoma and discusses its radiologic differential diagnosis.
Biomarker and diagnostic research for cystic renal cell carcinoma has been reported in the published literature.
No clinical trials have been registered for cystic renal cell carcinoma.
49 publications have been identified in PubMed for cystic renal cell carcinoma. Research spans Case Report / Case Series (47%), Diagnostic / Biomarker (16%), and Review / Meta-Analysis (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 23 | 47% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 11:24 AM UTC
8 |
16% |
Research summaries | 8 | 16% |
Clinical study results | 5 | 10% |
Laboratory research | 5 | 10% |
Bhardwaj S (2026). [PMID: 42155824](https://pubmed.ncbi.nlm.nih.gov/42155824/). *Hum Pathol*. [Diagnostic / Biomarker]
Glessgen CG (2026). [PMID: 42101309](https://pubmed.ncbi.nlm.nih.gov/42101309/). *Radiol Imaging Cancer*. [Diagnostic / Biomarker]
Trpkov K (2026). [PMID: 41384711](https://pubmed.ncbi.nlm.nih.gov/41384711/). *Histopathology*. [Review / Meta-Analysis]
Akdagcik Z (2026). [PMID: 41814368](https://pubmed.ncbi.nlm.nih.gov/41814368/). *Journal of medical case reports*. [Review / Meta-Analysis]
Do HL (2026). [PMID: 41815733](https://pubmed.ncbi.nlm.nih.gov/41815733/). *Urology case reports*. [Case Report / Case Series]
Zhao L (2026). [PMID: 40542967](https://pubmed.ncbi.nlm.nih.gov/40542967/). *International urology and nephrology*. [Clinical Trial Publication]
Toma MI (2026). [PMID: 41344358](https://pubmed.ncbi.nlm.nih.gov/41344358/). *Aktuelle Urologie*. [Review / Meta-Analysis]
Tekin B (2026). [PMID: 41500272](https://pubmed.ncbi.nlm.nih.gov/41500272/). *Human pathology*. [Case Report / Case Series]
Zheng S (2026). [PMID: 41882597](https://pubmed.ncbi.nlm.nih.gov/41882597/). *BMC Cancer*. [Basic Science / Preclinical]
Shah Rashdi PS (2026). [PMID: 42078616](https://pubmed.ncbi.nlm.nih.gov/42078616/). *Ann Med Surg (Lond)*. [Case Report / Case Series]